Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
The FDA has approved natalizumab (Tysabri) for the treatment of moderate-to-severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are…
The CDC’s FluView, a weekly influenza surveillance report prepared by the influenza division, posts the statistics for influenza week 6, February 3 – February 9, 2008. References and…
Gilbert E. D’Alonzo, MD, Professor of Medicine, Temple University School of Medicine, discusses heparin prophylaxis. References and Resources Chibbaro S, Tacconi L. Safety of deep venous thrombosis prophylaxis…
The FDA cleared for marketing the first replacement heart valve from donated human tissue in which the cells have been removed. References and Resources FDA Clears for Market…
Steven G. Kelsen, MD, FACP, FCCP, Professor of Medicine, Microbiology, and Immunology, Temple University School of Medicine, discusses how one can try to alleviate household allergens. References and…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses pediatric emergency care. References…
Steven G. Kelsen, MD, FACP, FCCP, Professor of Medicine, Microbiology, and Immunology, Temple University School of Medicine, discusses dust mites. References and Resources Thomas WR, Heinrich TK, Smith…
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses the uniqueness of a breast cancer…
Paula Busse, MD, Assistant Professor, Medicine and Clinical Immunology, Mount Sinai School of Medicine, discusses how to diagnose hereditary angioedema. References and Resources Bernstein JA. Hereditary angioedema: a…
The results of a phase II, multicenter trial that included 25 adult patients with newly diagnosed disease reported that patients maintained a complete response to treatment with high-dose…
